Clinical trial
Consequences of Eccentric Cycling on Exercise-related Neuromuscular Responses and Biomarkers in Breast Cancer Patients
NCT05166148 is registered in ClinicalTrials.gov with Institut de cancérologie Strasbourg Europe as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Consequences of Eccentric Cycling on Exercise-related Neuromuscular Responses and Biomarkers in Breast Cancer Patients
- Lead sponsor
- Institut de cancérologie Strasbourg Europe
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 22, 2021
- Completion date
- April 28, 2022
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer